Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2 ; volume:21 ; number:1 ; day:3 ; month:9 ; year:2024 ; pages:1-10 ; date:12.2024
Virology journal ; 21, Heft 1 (3.9.2024), 1-10, 12.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Goh, Vanessa Shi Li
Ang, Christopher Chong Wei
Low, Swee Ling
Lee, Pei Xuan
Setoh, Yin Xiang
Wong, Judith Chui Ching
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-024-02459-y
- URN
-
urn:nbn:de:101:1-2411261047103.421735517665
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goh, Vanessa Shi Li
- Ang, Christopher Chong Wei
- Low, Swee Ling
- Lee, Pei Xuan
- Setoh, Yin Xiang
- Wong, Judith Chui Ching
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Neutralizing topological obstructions to bubbles of nothing
Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection
Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Neutralizing topological obstructions to bubbles of nothing
Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection
Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Neutralizing topological obstructions to bubbles of nothing
Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection
Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus